Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By



Set Alert for Vaccines

Bimeda enters biologicals space with purchase of Texas business

Ireland's Bimeda has acquired Texas Vet Lab (TVL) and moved into the veterinary vaccine sector.

Bimeda Deals

Bioinnovo, Algenex reinforce vaccine molecule arrangement

Argentina's Bioinnovo has updated its partnership with Spanish firm Algenex for the use of a molecule developed by the latter.

Vaccines Food Animals

Verovaccines secures debut development partner, bags funding

German biotechnology start-up Verovaccines has signed an agreement with an unnamed Japanese company for the joint development of an animal vaccine.

Vaccines Investments

Ceva calls on mutual interest from all stakeholders for disease prevention

The animal health industry's increasing shift from treatment to prevention should be mirrored by all stakeholders, according to one of Ceva Santé Animale's management team.

Ceva Sante Animale Vaccines

Algenex adds to Fatro relationship with second vaccine license

Spanish start-up Algenex has entered another commercial license agreement with Italy's Fatro for development of a swine vaccine. 

R&D Deals

Breakthrough Roslin study could instigate better poultry vaccine design

The Roslin Institute claims a gene active in specialized chicken gut cells – CSF1R – could pave the way for studies exploring better design of vaccines.

Poultry Vaccines

MSD boosts LatAm aqua division with tilapia vaccine launch, eyes full roll-out by 2020

MSD Animal Health is to introduce Aquavac Strep Sa-Si – a vaccine that protects against streptococcosis in fish – throughout Latin America.

Merck MSD Animal Health Aquaculture

Intervacc completes Strangvac validation production process

Swedish firm Intervacc has finished the manufacturing stage of validation production batches for vaccine candidate Strangvac.

Vaccines Equine

Equine grass sickness trial fails to prove vaccine benefits

A UK-wide field trial aimed at determining the efficacy of a vaccine to prevent equine grass sickness (EGS) has failed to provide proof of its effectiveness.

Research Equine

Japanese start-up to develop vet vaccines using silkworms

Fukuoka City's Kaico is using a specific silkworm strain – Bombyx mori – to express medical-use proteins for the development veterinary vaccines.

R&D Vaccines

Labiana secures second animal health acquisition, expands footprint with Serbian firm

Spain's Labiana Life Sciences has acquired vaccines and chemotherapy specialist Veterinarski Zavod Subotica.

Vaccines M&A

Animal Pharm Awards 2019 now open for nominations

Subscribers have five weeks to nominate their company and innovations as part of the Animal Pharm Awards for 2019.

Europe North America
See All